|
|
Gene Symbol |
IGFBP2 |
|
Aliases |
IBP2, IGF-BP53 |
|
Entrez Gene ID |
|
|
Gene Name |
Insulin like growth factor binding protein 2 |
|
Chromosomal Location |
2q35 |
|
HGNC ID |
|
|
Summary |
The protein encoded by this gene is one of six similar proteins that bind insulin-like growth factors I and II (IGF-I and IGF-II). The encoded protein can be secreted into the bloodstream, where it binds IGF-I and IGF-II with high affinity, or it can remain intracellular, interacting with many different ligands. High expression levels of this protein promote the growth of several types of tumors and may be predictive of the chances of recovery of the patient. Several transcript variants, one encoding a secreted isoform and the others encoding nonsecreted isoforms, have been found for this gene. [provided by RefSeq, Sep 2015]
|
|
e!Ensembl
|
Protein Information |
|
Protein Name |
Insulin-like growth factor-binding protein 2, IGF-binding protein 2, insulin-like growth factor binding protein 2, 36kDa |
|
Function |
Inhibits IGF-mediated growth and developmental rates. IGF-binding proteins prolong the half-life of the IGFs and have been shown to either inhibit or stimulate the growth promoting effects of the IGFs on cell culture. They alter the interaction of IGFs with their cell surface receptors. |
|
|
UniProt |
|
|
PDB |
|
|
|
|
Interactions |
| |
STRING |
MINT |
IntAct |
ENSP00000305372 |
P07550 |
P07550 |
|
| |
View interactions
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Digestive System Diseases |
Liver Cirrhosis |
|
Liver Fibrosis |
|
Endocrine System Diseases |
PCOS |
|
Neoplasms |
Salivary Gland Neoplasms |
|
Adenoid Cystic Carcinoma |
|
Nutritional and Metabolic Diseases |
Obesity |
|
Psychiatric/Brain disorders |
Bipolar Disorder |
|
Skin and Connective Tissue Diseases |
Dermatitis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
IGFBP-1,IGFBP-4 |
|
|
|
Related
|
|
These results demonstrate that androgen and insulin are important regulators of IGFBP release and that elevated levels of the two hormones may contribute to the altered IGFBP profile found in PCOS follicles, compared with the case of estrogen-dominant follicles. |
|
IGFBP-3,IGFBP-4 and TGF-beta |
|
|
|
Related
|
|
The results of this studies indicate that IGFBP-2, IGFBP-4, and the 29K BP are significantly increased in PCO FF and that gonadotropins and TGF-beta regulate the production of IGFBPs by human theca and granulosa cells. |
|
IGFBP-3,IGFBP-4 |
Atresia |
|
|
Related
|
|
These data support the hypothesis that decreased concentrations of IGFBP, in particular IGFBP-3, may be involved in selection of the dominant follicle, and that when a spontaneous pre-ovulatory follicle develops in PCOS, the underlying cause of the polycystic ovaries is not resolved but the rest of the ovary remains polycystic. |
|
|
|
|